Pharyngeal Neoplasms - 100 Studies Found
Recruiting |
: Integrated Cancer Repository for Cancer Research :
|
Recruiting |
: 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy :
|
Recruiting |
: Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck :
|
Active, not recruiting |
: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. :
|
Withdrawn |
: Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract :
: |
Completed |
: Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy : Nasopharyngeal Neoplasms : 2008-02-25 : Drug: Pemetrexed (Alimta) 500 mg/m2 in Cycle 1, every 3 weeks, with folic acid and vitamin B12 supplemen |
Completed |
: Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) : Nasopharyngeal Neoplasms : 2008-09-04 : Drug: Sorafenib plus Cisplatin and 5-fluorouracil Sorafeni |
Not yet recruiting |
: Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2017-03-16 :
|
Recruiting |
: A Trial of Endostar in Patients With Carcinoma of the Head and Neck : Nasopharyngeal Neoplasms : 2016-08-12 : Drug: Endostar The patients will be randomized to CRT arm and CRT+Endostar arm. All patients will receiv |
Recruiting |
: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122) : : 2024-05-13 |